Global Cancer Diagnostics Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • ID: 4412614
  • Report
  • Region: Global
  • 294 pages
  • Data Bridge Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • C. R. Bard, Inc.
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Hologic Inc.
  • MORE

In this region, global cancer diagnostics is projected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

Based on geography, the global cancer diagnostics market is segmented into 5 geographical regions, such as:

  • North America
  • South America
  • Europe
  • APAC
  • MEA
  • Rest Of the World

Global cancer diagnostics market competition by top players including:

GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as

  • Hologic, Inc
  • Becton, Dickinson & Company.

Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as

  • Roche Diagnostics
  • Abbott Laboratories, Inc.
  • Qiagen.

The global cancer diagnostics market is segmented on the basis of technology, application and geography.

The global cancer diagnostics market is segmented into 2 types, namely platform based and instrument based.

Cancer diagnostics platform based market is segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others.

Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound.

On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • C. R. Bard, Inc.
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Hologic Inc.
  • MORE

1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of Global Cancer Diagnostics Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered for the Study
2.4. Currency and Pricing
2.5. Research Methodology
2.6. Primary Interviews with Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview
3.1. Drivers
3.1.1. Growth of Aging Population and Rising Prevalence of Cancer
3.1.2. Government Initiatives for Funding and Awareness About Cancer
3.1.3. Key Players Focusing on Strategic Decisions to Gain Market Share
3.1.4. Increasing Prevelance of Cancer
3.2. Restraints
3.2.1. Stringent Regulations Imposed by International and Local Authorities
3.2.2. Shortage of Skilled and Trained Professionals
3.3. Opportunities
3.3.1. Nanotechnology: Forthcoming Revolution in Cancer Diagnosis
3.3.2. Artificial Intelligence and the Imminent Health Revolution
3.3.3. Growing Medical Tourism in Asia
3.4. Challenges
3.4.1. Increasing Rivalry Among the Competitors
3.4.2. Poor Access to Cancer Detection and High Treatment Costs in Lower Income Countries

4. Premium Insights

5. Executive Summary

6. Global Cancer Diagnostics Market, by Technology
6.1. Overview
6.2. Platform Based
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. In Situ Hybridization (ISH)
6.2.3. Immunohistochemistry (IHC)
6.2.4. Next Generation Sequencing (NGS)
6.2.5. Dna Microarrays
6.2.6. Flow Cytometry
6.3. Instrument Based
6.3.1. Imaging
6.3.1.1. Magnetic Resonance Imaging (MRI)
6.3.1.2. CT (Computed Tomography)
6.3.1.3. Positron Emission Tomography- Computed Tomography (PET-CT)
6.3.1.4. Mammography
6.3.1.5. Ultrasound
6.3.2. Biopsy

7. Global Cancer Diagnostics Market, by Application
7.1. Overview
7.2. Lung Cancer
7.3. Breast Cancer
7.4. Colorectal Cancer
7.5. Melanoma
7.6. Others

8. Global Cancer Diagnostics Market, by Geography
8.1. Overview
8.2. North America Cancer Diagnostics Market
8.2.1. U.S. Cancer Diagnostics Market
8.2.2. Canada Cancer Diagnostics Market
8.2.3. Mexico Cancer Diagnostics Market
8.3. Europe Cancer Diagnostics Market
8.3.1. Germany Cancer Diagnostics Market
8.3.2. France Cancer Diagnostics Market
8.3.3. U.K. Cancer Diagnostics Market
8.3.4. Italy Cancer Diagnostics Market
8.3.5. Spain Cancer Diagnostics Market
8.3.6. Russia Cancer Diagnostics Market
8.3.7. Turkey Cancer Diagnostics Market
8.3.8. Belgium Cancer Diagnostics Market
8.3.9. Netherlands Cancer Diagnostics Market
8.3.10. Switzerland Cancer Diagnostics Market
8.3.11. Rest of Europe Cancer Diagnostics Market
8.4. APAC Cancer Diagnostics Market
8.4.1. Japan Cancer Diagnostics Market
8.4.2. China Cancer Diagnostics Market
8.4.3. India Cancer Diagnostics Market
8.4.4. South Korea Cancer Diagnostics Market
8.4.5. Australia Cancer Diagnostics Market
8.4.6. Thailand Cancer Diagnostics Market
8.4.7. Singapore Cancer Diagnostics Market
8.4.8. Malaysia Cancer Diagnostics Market
8.4.9. Indonesia Cancer Diagnostics Market
8.4.10. Philippines Cancer Diagnostics Market
8.4.11. Rest of APAC Cancer Diagnostics Market
8.5. South America Cancer Diagnostics Market
8.5.1. Brazil Cancer Diagnostics Market
8.5.2. Rest of South America Cancer Diagnostics Market
8.6. MEA Cancer Diagnostics Market
8.6.1. South Africa Cancer Diagnostics Market
8.6.2. Rest of MEA Cancer Diagnostics Market

9. Global Cancer Diagnostics Market, Company Landscape
9.1. Company Share Analysis: Global Cancer Diagnostics Imaging Market
9.2. Company Share Analysis: Global Cancer Diagnostics Platform Based Market

10. Company Profiles
10.1. C. R. Bard, Inc.
10.1.1. Company Overview
10.1.2. Revenue Analysis
10.1.3. Product Portfolio
10.1.4. Recent Developments
10.2. Illumina, Inc.
10.2.1. Company Overview
10.2.2. Revenue Analysis
10.2.3. Recent Developments
10.2.4. Product Portfolio
10.3. Qiagen
10.3.1. Company Overview
10.3.2. Revenue Analysis
10.3.3. Recent Developments
10.3.4. Product Portfolio
10.4. Abbott
10.4.1. Company Overview
10.4.2. Revenue Analysis
10.4.3. Recent Developments
10.4.4. Product Portfolio
10.5. Siemens Healthcare Gmbh
10.5.1. Company Overview
10.5.2. Revenue Analysis
10.5.3. Recent Developments
10.5.4. Product Portfolio
10.6. Agilent Technologies
10.6.1. Company Overview
10.6.2. Revenue Analysis
10.6.3. Product Portfolio
10.6.4. Recent Developments
10.7. Thermo Fisher Scientific Inc.
10.7.1. Company Overview
10.7.2. Revenue Analysis
10.7.3. Product Portfolio
10.7.4. Recent Developments
10.8. Becton, Dickinson and Company
10.8.1. Company Overview
10.8.2. Revenue Analysis
10.8.3. Product Portfolio
10.8.4. Recent Developments
10.9. GE Healthcare
10.9.1. Company Overview
10.9.2. Revenue Analysis
10.9.3. Product Portfolio
10.9.4. Recent Developments
10.10. F. Hoffmann-La Roche Ltd
10.10.1. Company Overview
10.10.2. Revenue Analysis
10.10.3. Product Portfolio
10.10.4. Recent Developments
10.11. Hologic Inc.
10.11.1. Company Overview
10.11.2. Revenue Analysis
10.11.3. Recent Developments
10.11.4. Product Portfolio
10.12. Koninklijhe Philips N.V.
10.12.1. Company Overview
10.12.2. Revenue Analysis
10.12.3. Product Portfolio
10.12.4. Recent Developments

11. Related Reports

List of Tables:
Table 1 Global Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 2 Global Platform Based Cancer Diagnostics Market, by Region, 2015- 2024 (USD Million)
Table 3 Global Polymerase Chain Reaction Market, by Region, 2015- 2024 (USD Million)
Table 4 Global in Situ Hybridization Market, by Region, 2015- 2024 (USD Million)
Table 5 Global Immunohistochemistry Market, by Region, 2015- 2024 (USD Million)
Table 6 Global Next Generation Sequencing Market, by Region, 2015- 2024 (USD Million)
Table 7 Global Dna Microarrays Market, by Region, 2015- 2024 (USD Million)
Table 8 Global Flow Cytometry Market, by Region, 2015- 2024 (USD Million)
Table 9 Global Instrument Based Cancer Diagnostics Market, by Region, 2015- 2024 (USD Million)
Table 10 Global Instrument Based Cancer Diagnostics Market, by Imaging by Region, 2015- 2024 (USD Million)
Table 11 Global Instrument Based Cancer Diagnostics Market, by Biopsy , by Region, 2015- 2024 (USD Million)
Table 12 Global Cancer Diagnostics Market, by Application, 2015 - 2024 (USD Million)
Table 13 Worldwide Lung Cancer Incidences
Table 14 Global Cancer Diagnostics Market, Lung Cancer, Byregion, 2015 - 2024 (USD Million)
Table 15 Worldwide Breast Cancer Incidences
Table 16 Global Cancer Diagnostics Market, by Breast Cancer, by Region, 2015 - 2024 (USD Million)
Table 17 Worldwide Colorectal Cancer Incidences
Table 18 Global Cancer Diagnostics Market, by Colorectal Cancer, by Region, 2015 - 2024 (USD Million)
Table 19 Worldwide Melanoma Cancer Incidences
Table 20 Global Cancer Diagnostics Market, by Melanoma , by Region2015 - 2024 (USD Million)
Table 21 Estimated New Cases of Cancer in 2017
Table 22 Global Cancer Diagnostics Market, by Others, by Region, 2015 - 2024 (USD Million)
Table 23 Global Cancer Diagnostics Market, by Geography, 2015 - 2024 (USD Million)
Table 24 North America Cancer Diagnostics Market, by Country, 2015 - 2024 (USD Million)
Table 25 North America Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 26 North America Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 27 North America Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 28 North America Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 29 North America Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 30 U.S.Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 31 U.S. Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 32 U.S. Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 33 U.S. Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 34 U.S. Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 35 Canada Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 36 Canada Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 37 Canada Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 38 Canada Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 39 Canada Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 40 Mexico Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 41 Mexico Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 42 Mexico Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 43 Mexico Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 44 Mexico Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 45 Europe Cancer Diagnostics Market, by Country, 2015 - 2024(USD Million)
Table 46 Europe Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 47 Europe Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 48 Europe Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 49 Europe Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 50 Europe Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 51 Germany Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 52 Germany Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 53 Germany Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 54 Germany Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 55 Germany Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 56 France Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 57 France Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 58 France Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 59 France Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 60 France Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 61 U.K. Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 62 U.K. Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 63 U.K. Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 64 U.K. Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 65 U.K. Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 66 Italy Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 67 Italy Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 68 Italy Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 69 Italy Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 70 Italy Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 71 Spain Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 72 Spain Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 73 Spain Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 74 Spain Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 75 Spain Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 76 Russia Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 77 Russia Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 78 Russia Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 79 Russia Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 80 Russia Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 81 Turkey Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 82 Turkey Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 83 Turkey Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 84 Turkey Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 85 Turkey Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 86 Belgium Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 87 Belgium Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 88 Belgium Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 89 Belgium Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 90 Belgium Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 91 Netherlands Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 92 Netherlands Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 93 Netherlands Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 94 Netherlands Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 95 Netherlands Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)
Table 96 Switzerland Cancer Diagnostics Market, by Technology, 2015 - 2024 (USD Million)
Table 97 Switzerland Platform Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 98 Switzerland Instrument Based Cancer Diagnostics Market, by Product Type, 2015 - 2024 (USD Million)
Table 99 Switzerland Instrument Based Cancer Diagnostics Market, by Imaging Type, 2015 - 2024 (USD Million)
Table 100 Switzerland Cancer Diagnostics Market, by Application 2015 - 2024 (USD Million)

List of Figures:
Figure 1 Global Cancer Diagnostics Market: Segmentatio
Figure 2 Global Cancer Diagnostics Market: Geograhic Scop
Figure 3 Global Cancer Diagnostics Market: Data Triangulatio
Figure 4 Global Cancer Diagnostics Market: Snapshot
Figure 5 Global Cancer Diagnostics Market: Bottom Up Approach
Figure 6 Global Cancer Diagnostics Market: Top Down Approach
Figure 7 Global Cancer Diagnostics Market: Interviews by Region and Designation
Figure 8 Drivers, Restraints, Opportunities, and Challenges of the Cancer Diagnostics Market
Figure 9 Population Aged Over 60 (Millions) (2010 vs 2050)
Figure 10 Technological Advancements in the Diagnostics Imaging Systems and Growing Number of Cancer Patients Is Expected to Drive the Market for Cancer Diagnostics Market in the Forecast Period 2017 to 2024
Figure 11 Instrument Based Market Segment Is Expected to Account for the Largest Share of the Cancer Diagnostics Market in 2017
Figure 12 Asia-Pacific and South America Are the Highest Growing and Most Profitable Revenue Pockets for Cancer Diagnostics Manufacturers in the Forecast Period 2017 to 2024
Figure 13 North America Dominates the Market for Cancer Diagnostics in 2016 and Is Expected to Continue This Trend in the Forecast Period to 2024
Figure 14 Global Cancer Diagnostics Market,Segmentation: by Technnology
Figure 15 Global Cancer Diagnostics Market: by Technology, Snapshot 2016
Figure 16 Global Cancer Diagnosticsmarket: by Application, Snapshot 2016
Figure 17 North America Cancer Diagnostics Market Snapshot (2017)
Figure 18 North America Cancer Diagnostics Market, by Country (2016)
Figure 19 North America Cancer Diagnostics Market : by Country (2017)
Figure 20 North America Cancer Diagnostics Market by Country (2016 & 2024)
Figure 21 North America Cancer Diagnostics Market, by Technology (2017 & 2024)
Figure 22 European Union Population Ages 65 and Above (% of Total)
Figure 23 Europe Cancer Diagnostics Market Snapshot (2017)
Figure 24 Europe Cancer Diagnostics Market, by Country (2016)
Figure 25 Europe Cancer Diagnostics Market by Country (2017)
Figure 26 Europe Cancer Diagnostics Market by Country (2016 & 2024)
Figure 27 Europe Cancer Diagnostics Market by Technology (2017 & 2024)
Figure 28 APAC Cancer Diagnostics Market : Snapshot (2017)
Figure 29 Apac Cancer Diagnostics Market, by Country (2016)
Figure 30 Apac Cancer Diagnostics Market : by Country (2017)
Figure 31 Apac Cancer Diagnostics Market by Country (2016 & 2024)
Figure 32 APAC Cancer Diagnostics Market, by Technology (2017 & 2024)
Figure 33 South America Cancer Diagnostics Market Snapshot (2017)
Figure 34 South America Cancer Diagnostics Market, by Country (2016)
Figure 35 South America Cancer Diagnostics Market : by Country (2017)
Figure 36 South America Cancer Diagnostics Market by Country (2016 & 2024)
Figure 37 South America Cancer Diagnostics Market, by Technology (2017 & 2024)
Figure 38 MEA Cancer Diagnostics Market: Snapshot (2017)
Figure 39 MEA Cancer Diagnostics Market, by Country (2016)
Figure 40 MEA Cancer Diagnostics Market: by Country (2017)
Figure 41 MEA Cancer Diagnostics Market: by Country (2016 & 2024)
Figure 42 MEA Cancer Diagnostics Market: by Technology (2016 & 2024)
Figure 43 Global Cancer Diagnostics Market: by Imaging, Company Share 2016 (%)
Figure 44 Global Cancer Diagnostics Market: by Platform Based, Company Share 2016 (%)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Agilent Technologies
  • Becton, Dickinson and Company
  • C. R. Bard, Inc.
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Hologic Inc.
  • Illumina, Inc.
  • Koninklijhe Philips N.V.
  • Qiagen
  • Siemens Healthcare Gmbh
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll